BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191119T080000
DTEND;TZID=America/New_York:20191120T170000
DTSTAMP:20260716T043356
CREATED:20191112T125745Z
LAST-MODIFIED:20191112T125745Z
UID:7167-1574150400-1574269200@scienceinboston.com
SUMMARY:Harvard Medical School Master’s Degree Program Info Session
DESCRIPTION:Overview\n\nHarvard Medical School faculty will host an in-person information session for three Master’s Degree Program offerings: Master in Clinical Service Operations; Master of Healthcare Quality and Safety; and Master of Medical Science in Clinical Investigation. \nThe faculty created these Programs to address the needs of clinician-scientists working in clinical or translational research and clinicians and administrators in clinical service operations and health care quality and safety. All three degrees combine innovative forms of pedagogy from leading Harvard faculty with an individual mentor experience in a Harvard affiliated laboratory or with a practical application at Harvard’s academic medical centers and community hospitals. \nLearn more and register\, click here \nMaster of Medical Science in Clinical Investigation \nThis program provides world-class training in the methods and conduct of clinical investigation for future leaders in patient-oriented research. New this year\, a Translational Track and pathways have been added on comparative research and clinical trials. \nMaster in Clinical Service Operations \nThis clinical service operations program provides physicians\, clinicians\, nurses\, allied health professionals and administrators with the operations management training they need to lead teams\, optimize efficiency and improve the patient experience. \nMaster of Healthcare Quality and Safety \nThis program provides clinicians and clinical administrators with the operational skills to lead and work effectively in quality improvement and safety initiatives within their health care organizations. \n 
URL:https://scienceinboston.com/event/harvard-medical-school-masters-degree-program-info-session/
LOCATION:Harvard Medical School\, 25 Shattuck St\, Boston\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191119T080000
DTEND;TZID=America/New_York:20191120T170000
DTSTAMP:20260716T043356
CREATED:20191112T125745Z
LAST-MODIFIED:20191112T125745Z
UID:27383-1574150400-1574269200@scienceinboston.com
SUMMARY:Harvard Medical School Master’s Degree Program Info Session
DESCRIPTION:Overview\n\nHarvard Medical School faculty will host an in-person information session for three Master’s Degree Program offerings: Master in Clinical Service Operations; Master of Healthcare Quality and Safety; and Master of Medical Science in Clinical Investigation. \nThe faculty created these Programs to address the needs of clinician-scientists working in clinical or translational research and clinicians and administrators in clinical service operations and health care quality and safety. All three degrees combine innovative forms of pedagogy from leading Harvard faculty with an individual mentor experience in a Harvard affiliated laboratory or with a practical application at Harvard’s academic medical centers and community hospitals. \nLearn more and register\, click here \nMaster of Medical Science in Clinical Investigation \nThis program provides world-class training in the methods and conduct of clinical investigation for future leaders in patient-oriented research. New this year\, a Translational Track and pathways have been added on comparative research and clinical trials. \nMaster in Clinical Service Operations \nThis clinical service operations program provides physicians\, clinicians\, nurses\, allied health professionals and administrators with the operations management training they need to lead teams\, optimize efficiency and improve the patient experience. \nMaster of Healthcare Quality and Safety \nThis program provides clinicians and clinical administrators with the operational skills to lead and work effectively in quality improvement and safety initiatives within their health care organizations. \n 
URL:https://scienceinboston.com/event/harvard-medical-school-masters-degree-program-info-session-2/
LOCATION:Harvard Medical School\, 25 Shattuck St\, Boston\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191120T150000
DTEND;TZID=America/New_York:20191120T180000
DTSTAMP:20260716T043356
CREATED:20191118T150525Z
LAST-MODIFIED:20191118T150525Z
UID:7224-1574262000-1574272800@scienceinboston.com
SUMMARY:Intersectionality Conference
DESCRIPTION:Description\nGlobal Diversity and Inclusion at Biogen invites you to attend our upcoming Intersectionality Conference! Join us for an engaging conversation on the importance of empathy\, mindfulness and appreciation towards others’ intersecting identities and on issues faced by individuals with overlapping underrepresented identities. In addition to two moderated panel discussions\, we will also screen a powerful TedX video focused on intersectionality. \nThe future is #Intersectional. \nAgenda: \n3:00 PM – 3:15 PM: Opening remarks \n3:15 PM – 3:30 PM: TedX Video on Intersectionality \n3:30 PM – 4:15 PM: Panel Discussion: Intersectional Perspectives moderated by Nicholas J. Everage\, Director\, Epidemiology at Biogen \n4:15 PM – 5:00 PM: Panel Discussion: Bringing Intersectionality to Life moderated by Ryan MacLean\, Director\, Global Inclusion at Biogen \n5:00 PM – 6:00 PM: Networking Reception and Live Music \nIf you require any additional accommodations\, please email jeffrey.herrera@biogen.com or abhishek.verma@biogen.com
URL:https://scienceinboston.com/event/intersectionality-conference/
LOCATION:Biogen Building 9\, 300 Binney Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191120T150000
DTEND;TZID=America/New_York:20191120T180000
DTSTAMP:20260716T043356
CREATED:20191118T150525Z
LAST-MODIFIED:20191118T150525Z
UID:27387-1574262000-1574272800@scienceinboston.com
SUMMARY:Intersectionality Conference
DESCRIPTION:Description\nGlobal Diversity and Inclusion at Biogen invites you to attend our upcoming Intersectionality Conference! Join us for an engaging conversation on the importance of empathy\, mindfulness and appreciation towards others’ intersecting identities and on issues faced by individuals with overlapping underrepresented identities. In addition to two moderated panel discussions\, we will also screen a powerful TedX video focused on intersectionality. \nThe future is #Intersectional. \nAgenda: \n3:00 PM – 3:15 PM: Opening remarks \n3:15 PM – 3:30 PM: TedX Video on Intersectionality \n3:30 PM – 4:15 PM: Panel Discussion: Intersectional Perspectives moderated by Nicholas J. Everage\, Director\, Epidemiology at Biogen \n4:15 PM – 5:00 PM: Panel Discussion: Bringing Intersectionality to Life moderated by Ryan MacLean\, Director\, Global Inclusion at Biogen \n5:00 PM – 6:00 PM: Networking Reception and Live Music \nIf you require any additional accommodations\, please email jeffrey.herrera@biogen.com or abhishek.verma@biogen.com
URL:https://scienceinboston.com/event/intersectionality-conference-2/
LOCATION:Biogen Building 9\, 300 Binney Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191120T153000
DTEND;TZID=America/New_York:20191120T170000
DTSTAMP:20260716T043356
CREATED:20191118T151454Z
LAST-MODIFIED:20191118T151454Z
UID:7228-1574263800-1574269200@scienceinboston.com
SUMMARY:Commercializing Innovation: Harvard Resources for Scientist-Entrepreneurs
DESCRIPTION:Description\nHarvard Resources for Scientist-Entrepreneurs\nFeatured Speakers\nJodi Goldstein\, Harvard Innovation Labs \nIfat Rubin-Bejerano\, Q-FASTR at Harvard Medical School\n \nCurtis Keith\, Blavatnik Biomedical Accelerator at Harvard University\n \nChris Petty\, Harvard Office of Technology Development \nDiscussion moderated by Jen Rice\, Harvard OTD \nThe “Commercializing Innovation” speaker series is hosted by Harvard Office of Technology Development and the FAS Office of Postdoctoral Affairs. The Commercializing Innovation speaker series is primarily intended for Harvard University faculty\, postdoctoral researchers\, and graduate students who are interested in learning about technology commercialization\, careers outside of academia\, and scientific entrepreneurship. However\, the event is open to all.\n \nThis talk may be of most value to those who are considering careers in a startup and/or who have created research innovations that could be commercialized. \nTo learn about other upcoming events\, visit https://otd.harvard.edu/events.\n \nWe are particularly pleased to be hosting\, through this series\, speakers who are members of Harvard OTD’s Experts-in-Residence (XIR) program\, a powerful resource for Harvard innovators working to commercialize a technology\, navigating the launch of a startup\, or seeking corporate partners. \nOTD’s XIRs have a wealth of experience in: company formation and leadership\, intellectual property strategy\, legal transactions\, product development\, regulatory affairs\, marketing\, corporate partnerships\, and much more. \nIf you are a Harvard researcher wishing to engage with an XIR\, simply contact otd@harvard.edu.
URL:https://scienceinboston.com/event/commercializing-innovation-harvard-resources-for-scientist-entrepreneurs/
LOCATION:Waterhouse Room \,Gordon Hall\, 1st Floor\, 25 Shattuck St\, Boston\, MA\, 02115\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191120T153000
DTEND;TZID=America/New_York:20191120T170000
DTSTAMP:20260716T043356
CREATED:20191118T151454Z
LAST-MODIFIED:20191118T151454Z
UID:27388-1574263800-1574269200@scienceinboston.com
SUMMARY:Commercializing Innovation: Harvard Resources for Scientist-Entrepreneurs
DESCRIPTION:Description\nHarvard Resources for Scientist-Entrepreneurs\nFeatured Speakers\nJodi Goldstein\, Harvard Innovation Labs \nIfat Rubin-Bejerano\, Q-FASTR at Harvard Medical School\n \nCurtis Keith\, Blavatnik Biomedical Accelerator at Harvard University\n \nChris Petty\, Harvard Office of Technology Development \nDiscussion moderated by Jen Rice\, Harvard OTD \nThe “Commercializing Innovation” speaker series is hosted by Harvard Office of Technology Development and the FAS Office of Postdoctoral Affairs. The Commercializing Innovation speaker series is primarily intended for Harvard University faculty\, postdoctoral researchers\, and graduate students who are interested in learning about technology commercialization\, careers outside of academia\, and scientific entrepreneurship. However\, the event is open to all.\n \nThis talk may be of most value to those who are considering careers in a startup and/or who have created research innovations that could be commercialized. \nTo learn about other upcoming events\, visit https://otd.harvard.edu/events.\n \nWe are particularly pleased to be hosting\, through this series\, speakers who are members of Harvard OTD’s Experts-in-Residence (XIR) program\, a powerful resource for Harvard innovators working to commercialize a technology\, navigating the launch of a startup\, or seeking corporate partners. \nOTD’s XIRs have a wealth of experience in: company formation and leadership\, intellectual property strategy\, legal transactions\, product development\, regulatory affairs\, marketing\, corporate partnerships\, and much more. \nIf you are a Harvard researcher wishing to engage with an XIR\, simply contact otd@harvard.edu.
URL:https://scienceinboston.com/event/commercializing-innovation-harvard-resources-for-scientist-entrepreneurs-2/
LOCATION:Waterhouse Room \,Gordon Hall\, 1st Floor\, 25 Shattuck St\, Boston\, MA\, 02115\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191120T180000
DTEND;TZID=America/New_York:20191120T193000
DTSTAMP:20260716T043356
CREATED:20191118T151702Z
LAST-MODIFIED:20191118T151702Z
UID:7232-1574272800-1574278200@scienceinboston.com
SUMMARY:BPDA Interview Series\, part #2B - Teaching statements 2.0
DESCRIPTION:Description\n\n\n\nPart 2B of the BPDA’s Academic Interview Preparation series is a follow-up to October 23rd’s excellent workshop with Sarah Hokanson.\n\nAnyone can attend part 2B! You did not need to be at 2A. As long as you have a teaching statement drafted\, you are most welcome to register for this workshop.\n\nFOllowing part 2A\, the group decided it would be benefical to utilize the skills from that workshop\, focused largely on the purpose & nuts and bolts of writing teaching statements\, by writing drafts and peer reviewing each other’s work.\n\n\n\nWorkshop Part 2B will happen on November 20th from 6:00-7:30pm\, and will work as follows:\n\n\n\nRegister via Eventbrite.\nPostdocs submit their statements one week prior to the workshop. We will create a link for uploading with relevant instructions and send via your registered email.\nParticipants will be matched ** IN ADVANCE** to read statements – usually in pairs. Please\, if you register for this event\, do your very best to attend. Your partner will be depending on you.\nPeer review happens inside the workshop.\nYou will disperse and be well-equipped to prepare your application packages!\n\n\n\nThe session will be hosted by Dr. Sarah Hokanson\, Assistant Provost\, Professional Development & Postdoctoral Affairs\, Boston University. Dr. Hokanson has extensive experience with postdoc career development and planning\, including interview documentation and interview preparation.\n\nDon’t miss it!\nThe BPDA Career Development Committee
URL:https://scienceinboston.com/event/bpda-interview-series-part-2b-teaching-statements-2-0/
LOCATION:Rajen Kilachand Center for Integrated Life Sciences and Engineering\, 610 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191120T180000
DTEND;TZID=America/New_York:20191120T193000
DTSTAMP:20260716T043356
CREATED:20191118T151702Z
LAST-MODIFIED:20191118T151702Z
UID:27389-1574272800-1574278200@scienceinboston.com
SUMMARY:BPDA Interview Series\, part #2B - Teaching statements 2.0
DESCRIPTION:Description\n\n\n\nPart 2B of the BPDA’s Academic Interview Preparation series is a follow-up to October 23rd’s excellent workshop with Sarah Hokanson.\n\nAnyone can attend part 2B! You did not need to be at 2A. As long as you have a teaching statement drafted\, you are most welcome to register for this workshop.\n\nFOllowing part 2A\, the group decided it would be benefical to utilize the skills from that workshop\, focused largely on the purpose & nuts and bolts of writing teaching statements\, by writing drafts and peer reviewing each other’s work.\n\n\n\nWorkshop Part 2B will happen on November 20th from 6:00-7:30pm\, and will work as follows:\n\n\n\nRegister via Eventbrite.\nPostdocs submit their statements one week prior to the workshop. We will create a link for uploading with relevant instructions and send via your registered email.\nParticipants will be matched ** IN ADVANCE** to read statements – usually in pairs. Please\, if you register for this event\, do your very best to attend. Your partner will be depending on you.\nPeer review happens inside the workshop.\nYou will disperse and be well-equipped to prepare your application packages!\n\n\n\nThe session will be hosted by Dr. Sarah Hokanson\, Assistant Provost\, Professional Development & Postdoctoral Affairs\, Boston University. Dr. Hokanson has extensive experience with postdoc career development and planning\, including interview documentation and interview preparation.\n\nDon’t miss it!\nThe BPDA Career Development Committee
URL:https://scienceinboston.com/event/bpda-interview-series-part-2b-teaching-statements-2-0-2/
LOCATION:Rajen Kilachand Center for Integrated Life Sciences and Engineering\, 610 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191121T160000
DTEND;TZID=America/New_York:20191122T120000
DTSTAMP:20260716T043356
CREATED:20191118T150140Z
LAST-MODIFIED:20191118T150140Z
UID:7219-1574352000-1574424000@scienceinboston.com
SUMMARY:The Barry L. Karger Medal Lectures and Award
DESCRIPTION:Description\nThursday\, November 21 \n3:30 PM Reception with refreshments \n4:00 PM Award and Public Lecture \nTitle: Advances in Glycomics and its Critical Role In Systems Biology \n5:30 PM Adjourn \nFriday\, November 22 \n10:00 AM Technical Lecture \nTitle: Automated Multidimensional Separations and Advanced Bioinformatics for Rapid Analysis and Control of Glycosylation in Bioprocessing \n12:00 PM Adjourn \n_________________________________________________________________________________ \nThe Barry L. Karger Medal Lectures and Award\, a biannual event hosted by Northeastern University’s College of Science and Barnett Institute for Chemical & Biological Analysis\, recognizes an individual who has contributed significantly to the development of new analytical methods using bioanalytical tecniques\, or research within a scientific field aligned with the Barnett Institute. The medal was established in honor of Northeastern University Professor and Barnett Institute Director Emeritus Barry Karger. \nThis year’s distinguished lecturer is Pauline Rudd\, Ph.D. Dr. Rudd is an Emeritus Fellow of the University College Dublin’s Conway Institute of Biomolecular and Biomedical Research. She is also a Visiting Investigator at the Bioprocessing Technology Institute\, AStar\, Singapore.
URL:https://scienceinboston.com/event/the-barry-l-karger-medal-lectures-and-award/
LOCATION:Raytheon Amphitheater\, 120 Forsyth Street\, Boston\, MA\, 02115\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191121T160000
DTEND;TZID=America/New_York:20191122T120000
DTSTAMP:20260716T043356
CREATED:20191118T150140Z
LAST-MODIFIED:20191118T150140Z
UID:27385-1574352000-1574424000@scienceinboston.com
SUMMARY:The Barry L. Karger Medal Lectures and Award
DESCRIPTION:Description\nThursday\, November 21 \n3:30 PM Reception with refreshments \n4:00 PM Award and Public Lecture \nTitle: Advances in Glycomics and its Critical Role In Systems Biology \n5:30 PM Adjourn \nFriday\, November 22 \n10:00 AM Technical Lecture \nTitle: Automated Multidimensional Separations and Advanced Bioinformatics for Rapid Analysis and Control of Glycosylation in Bioprocessing \n12:00 PM Adjourn \n_________________________________________________________________________________ \nThe Barry L. Karger Medal Lectures and Award\, a biannual event hosted by Northeastern University’s College of Science and Barnett Institute for Chemical & Biological Analysis\, recognizes an individual who has contributed significantly to the development of new analytical methods using bioanalytical tecniques\, or research within a scientific field aligned with the Barnett Institute. The medal was established in honor of Northeastern University Professor and Barnett Institute Director Emeritus Barry Karger. \nThis year’s distinguished lecturer is Pauline Rudd\, Ph.D. Dr. Rudd is an Emeritus Fellow of the University College Dublin’s Conway Institute of Biomolecular and Biomedical Research. She is also a Visiting Investigator at the Bioprocessing Technology Institute\, AStar\, Singapore.
URL:https://scienceinboston.com/event/the-barry-l-karger-medal-lectures-and-award-2/
LOCATION:Raytheon Amphitheater\, 120 Forsyth Street\, Boston\, MA\, 02115\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191122T090000
DTEND;TZID=America/New_York:20191122T150000
DTSTAMP:20260716T043357
CREATED:20191118T150258Z
LAST-MODIFIED:20191118T150258Z
UID:7222-1574413200-1574434800@scienceinboston.com
SUMMARY:Learn about Cambrex Early Stage offerings in Cambridge
DESCRIPTION:Overview\n\nJoin our experts to find out about our end-to-end offerings and early stage development capabilities \nCambrex hosts a series of presentations at MassBio discussing our early stage capabilities. Stop in and learn….. \nPractical application of continuous flow process development\nPresented by Dr. Shawn Conway | Director\, Engineering Research & Development | Cambrex High Point \nDesign of a kilo lab and mid-scale High Potent API (HPAPI) commercial facility\nPresented by Jason Korbel | Technical Services Manager | Cambrex Charles City \nThe Importance of understanding the solid form landscape of an API during early product development\nPresented by Dr. Jonathan Loughrey | Head of Screening Services | Cambrex Edinburgh \nAgenda:\n9:00 am    Check-in\n9:30 am    Presentation by Dr. Shawn Conway\n10:30 am    Break\n11:00 am    Presentation by Jason Korbel\n12:15 pm    Lunch\n1:30 pm    Presentation by Dr. Jonathan Loughrey\n2:30 pm    Wrap up \nRSVP:\nThis event is FREE but requires pre-registration. Email events@cambrex.com to register.\nLunch will be provided.
URL:https://scienceinboston.com/event/learn-about-cambrex-early-stage-offerings-in-cambridge/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191122T090000
DTEND;TZID=America/New_York:20191122T150000
DTSTAMP:20260716T043357
CREATED:20191118T150258Z
LAST-MODIFIED:20191118T150258Z
UID:27386-1574413200-1574434800@scienceinboston.com
SUMMARY:Learn about Cambrex Early Stage offerings in Cambridge
DESCRIPTION:Overview\n\nJoin our experts to find out about our end-to-end offerings and early stage development capabilities \nCambrex hosts a series of presentations at MassBio discussing our early stage capabilities. Stop in and learn….. \nPractical application of continuous flow process development\nPresented by Dr. Shawn Conway | Director\, Engineering Research & Development | Cambrex High Point \nDesign of a kilo lab and mid-scale High Potent API (HPAPI) commercial facility\nPresented by Jason Korbel | Technical Services Manager | Cambrex Charles City \nThe Importance of understanding the solid form landscape of an API during early product development\nPresented by Dr. Jonathan Loughrey | Head of Screening Services | Cambrex Edinburgh \nAgenda:\n9:00 am    Check-in\n9:30 am    Presentation by Dr. Shawn Conway\n10:30 am    Break\n11:00 am    Presentation by Jason Korbel\n12:15 pm    Lunch\n1:30 pm    Presentation by Dr. Jonathan Loughrey\n2:30 pm    Wrap up \nRSVP:\nThis event is FREE but requires pre-registration. Email events@cambrex.com to register.\nLunch will be provided.
URL:https://scienceinboston.com/event/learn-about-cambrex-early-stage-offerings-in-cambridge-2/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20191202T080000
DTEND;TZID=America/Vancouver:20191202T170000
DTSTAMP:20260716T043357
CREATED:20191118T152137Z
LAST-MODIFIED:20191118T152137Z
UID:7238-1575273600-1575306000@scienceinboston.com
SUMMARY:Cambridge Biomedical December 2nd - Lunch Event\, Enrollment and Retention in IO studies: Patient and Site Centricity
DESCRIPTION:Overview\n\nEnrollment and Retention in IO studies: Patient and Site Centricity \nAbstract \nEnrollment and patient retention remain the most significant barriers to executing successful randomized clinical trials for sponsor companies today\, impacting timeline\, quality\, and budget.  More than 80% of clinical studies fail to complete enrollment on time\, and approximately half of the sites selected for clinical trials enroll between zero and one patient. \nOvercoming the recruitment challenge requires a sponsor’s delicate coordination of multiple stakeholders\, all of whom have different goals and motivations:  CROs\, vendors\, regulators\, and the two most important partners\, investigators and the patients they are treating. \n  \nRapid developments in the immuno-oncology (IO) field in recent years offer both a challenge and an opportunity for drug developers to design and execute trials with patients and sites in mind (“patient and site centricity”).  The FDA has also evolved in its own patient engagement approach with programs like the Patient-Focused Drug Development (PFDD) initiative. \nKelly Brady\, Vice President\, Clinical Operations Seres Therapeutics \nKelly holds a BS degree in Neuroscience from Lafayette College\, and an MS in Biotechnology from Johns Hopkins where she began her career as a research associate in the Orthopaedic Oncology department.   Kelly  has held positions  of increasing responsibility in Clinical Operations and Clinical Program management over the past 12 years. \n  \nAs a clinical associate at Osiris Therapeutics\, Kelly managed global  pediatric and hematology projects (GVHD\, COPD)\, and was a member of the operational and submission team who worked on Prochymal\, an allogeneic stem cell therapy  which received approval for treatment of GVHD in children in Canada in 2012.  Following Osiris\,  Kelly moved to Millenium/Takeda where she was global phase 3 clinical leader for the Adcetris trials in Hodgkins Lymphoma\,  in conjunction with Seattle Genetics\, run in 29 countries.  Kelly then held positions in Operations and Program management at Acetylon\, and was a member of the team involved in the acquisition of the company by Celgene.  Prior to joining Seres\,  Kelly was  Senior Director\, Global Clinical Program Lead at Akebia\, overseeing the pivotal program including 4 Phase 3  cardiovascular outcomes studies in 27 countries\, and initiated a Clinical Trial Educator program in North America. \n  \nKelly continues to be active with the Leukemia and Lymphoma Society\, and lives in Cambridge with her husband.
URL:https://scienceinboston.com/event/cambridge-biomedical-december-2nd-lunch-event-enrollment-and-retention-in-io-studies-patient-and-site-centricity/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20191202T080000
DTEND;TZID=America/Vancouver:20191202T170000
DTSTAMP:20260716T043357
CREATED:20191118T152137Z
LAST-MODIFIED:20191118T152137Z
UID:27391-1575273600-1575306000@scienceinboston.com
SUMMARY:Cambridge Biomedical December 2nd - Lunch Event\, Enrollment and Retention in IO studies: Patient and Site Centricity
DESCRIPTION:Overview\n\nEnrollment and Retention in IO studies: Patient and Site Centricity \nAbstract \nEnrollment and patient retention remain the most significant barriers to executing successful randomized clinical trials for sponsor companies today\, impacting timeline\, quality\, and budget.  More than 80% of clinical studies fail to complete enrollment on time\, and approximately half of the sites selected for clinical trials enroll between zero and one patient. \nOvercoming the recruitment challenge requires a sponsor’s delicate coordination of multiple stakeholders\, all of whom have different goals and motivations:  CROs\, vendors\, regulators\, and the two most important partners\, investigators and the patients they are treating. \n  \nRapid developments in the immuno-oncology (IO) field in recent years offer both a challenge and an opportunity for drug developers to design and execute trials with patients and sites in mind (“patient and site centricity”).  The FDA has also evolved in its own patient engagement approach with programs like the Patient-Focused Drug Development (PFDD) initiative. \nKelly Brady\, Vice President\, Clinical Operations Seres Therapeutics \nKelly holds a BS degree in Neuroscience from Lafayette College\, and an MS in Biotechnology from Johns Hopkins where she began her career as a research associate in the Orthopaedic Oncology department.   Kelly  has held positions  of increasing responsibility in Clinical Operations and Clinical Program management over the past 12 years. \n  \nAs a clinical associate at Osiris Therapeutics\, Kelly managed global  pediatric and hematology projects (GVHD\, COPD)\, and was a member of the operational and submission team who worked on Prochymal\, an allogeneic stem cell therapy  which received approval for treatment of GVHD in children in Canada in 2012.  Following Osiris\,  Kelly moved to Millenium/Takeda where she was global phase 3 clinical leader for the Adcetris trials in Hodgkins Lymphoma\,  in conjunction with Seattle Genetics\, run in 29 countries.  Kelly then held positions in Operations and Program management at Acetylon\, and was a member of the team involved in the acquisition of the company by Celgene.  Prior to joining Seres\,  Kelly was  Senior Director\, Global Clinical Program Lead at Akebia\, overseeing the pivotal program including 4 Phase 3  cardiovascular outcomes studies in 27 countries\, and initiated a Clinical Trial Educator program in North America. \n  \nKelly continues to be active with the Leukemia and Lymphoma Society\, and lives in Cambridge with her husband.
URL:https://scienceinboston.com/event/cambridge-biomedical-december-2nd-lunch-event-enrollment-and-retention-in-io-studies-patient-and-site-centricity-2/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191202T180000
DTEND;TZID=America/New_York:20191202T210000
DTSTAMP:20260716T043357
CREATED:20191118T152259Z
LAST-MODIFIED:20191118T152259Z
UID:7241-1575309600-1575320400@scienceinboston.com
SUMMARY:Private Screening: In Their Shoes\, Unheard Stories of Reentry and Recovery
DESCRIPTION:Overview\n\nMassBio will be holding a private screening of In Their Shoes\, Unheard Stories of Reentry and Recovery\, a moving documentary which is set in Boston and explores the connection between mental health\, addiction\, and incarceration. The film will be followed by a panel featuring Dr Bertha Madras of Harvard Medical School and Former US Representative Patrick Kennedy\, both members of President Trump’s Commission on the Opioid Crisis. \nThe documentary recounts the journey of four men from addiction to prison and the complexity of their lives on the outside and is interspersed with interviews and commentary by Mayor Marty Walsh\, Congressman Joe Kennedy III\, Sheriff Michael Bellotti\, Professor Randall Horton\, and more. \nThe screening will be held at the MassBio office\, 300 Technology Square\, Cambridge on December 2nd. Registration and networking with refreshments and hors d’oeuvres will start at 6:00 pm and the documentary will begin at 6:30 pm. \nPlease join us on December 2nd and participate in this critical conversation. Your RSVP response is requested by November 18th\, via email to John Hallinan. \nMore info on the documentary can be found  at https://www.intheirshoesfilm.com/ and additional information on the sobering metrics of opioid abuse at Facts – In Their Shoes Film.
URL:https://scienceinboston.com/event/private-screening-in-their-shoes-unheard-stories-of-reentry-and-recovery/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191202T180000
DTEND;TZID=America/New_York:20191202T210000
DTSTAMP:20260716T043357
CREATED:20191118T152259Z
LAST-MODIFIED:20191118T152259Z
UID:27392-1575309600-1575320400@scienceinboston.com
SUMMARY:Private Screening: In Their Shoes\, Unheard Stories of Reentry and Recovery
DESCRIPTION:Overview\n\nMassBio will be holding a private screening of In Their Shoes\, Unheard Stories of Reentry and Recovery\, a moving documentary which is set in Boston and explores the connection between mental health\, addiction\, and incarceration. The film will be followed by a panel featuring Dr Bertha Madras of Harvard Medical School and Former US Representative Patrick Kennedy\, both members of President Trump’s Commission on the Opioid Crisis. \nThe documentary recounts the journey of four men from addiction to prison and the complexity of their lives on the outside and is interspersed with interviews and commentary by Mayor Marty Walsh\, Congressman Joe Kennedy III\, Sheriff Michael Bellotti\, Professor Randall Horton\, and more. \nThe screening will be held at the MassBio office\, 300 Technology Square\, Cambridge on December 2nd. Registration and networking with refreshments and hors d’oeuvres will start at 6:00 pm and the documentary will begin at 6:30 pm. \nPlease join us on December 2nd and participate in this critical conversation. Your RSVP response is requested by November 18th\, via email to John Hallinan. \nMore info on the documentary can be found  at https://www.intheirshoesfilm.com/ and additional information on the sobering metrics of opioid abuse at Facts – In Their Shoes Film.
URL:https://scienceinboston.com/event/private-screening-in-their-shoes-unheard-stories-of-reentry-and-recovery-2/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191203T080000
DTEND;TZID=America/New_York:20191203T170000
DTSTAMP:20260716T043357
CREATED:20191118T151945Z
LAST-MODIFIED:20191118T151945Z
UID:7235-1575360000-1575392400@scienceinboston.com
SUMMARY:Technical Seminar: Mass Cytometry for Highly Multiplexed Analysis
DESCRIPTION:Join for a technical seminar and luncheon: Mass Cytometry is advancing analysis. Register to learn more.\n\n\n\n\n\n\nAbout this Event\n\n\nYou are invited to this lunchtime seminar on CyTOF technology. \nAbstract: Revealing cellular variations in perceived homogenous populations has become crucial to characterizing immune responses\, understanding cancer cells\, tracking stem cell lineage\, and studying the effectiveness of biological therapies. Additionally\, the need for antibody-based high parameter protein analysis is underscored by its capacity to identify rare and previously uncharacterized cell populations. This ability has far reaching implications in both basic research and into translational research. \nSpeakers: \nDaniel Frederick\, PhD\, Mass Cytometry Application Scientist \nEric Swanson\, PhD\, Imaging Mass Cytometry Application Scientist \nIn this seminar: \n(a) we will describe the principles of the Helios™\, CyTOF® mass cytometry system\, the utility of high parameter analysis\, and highlight ground-breaking research made possible with mass cytometry. \n(b) we will describe the principles and workflow of the Hyperion™ Tissue Imaging System\, and highlight ground-breaking research made possible with imaging mass cytometry.
URL:https://scienceinboston.com/event/technical-seminar-mass-cytometry-for-highly-multiplexed-analysis/
LOCATION:Koch Institute for Integrative Cancer Research\, 500 Main Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191203T080000
DTEND;TZID=America/New_York:20191203T170000
DTSTAMP:20260716T043357
CREATED:20191118T151945Z
LAST-MODIFIED:20191118T151945Z
UID:27390-1575360000-1575392400@scienceinboston.com
SUMMARY:Technical Seminar: Mass Cytometry for Highly Multiplexed Analysis
DESCRIPTION:Join for a technical seminar and luncheon: Mass Cytometry is advancing analysis. Register to learn more.\n\n\n\n\n\n\nAbout this Event\n\n\nYou are invited to this lunchtime seminar on CyTOF technology. \nAbstract: Revealing cellular variations in perceived homogenous populations has become crucial to characterizing immune responses\, understanding cancer cells\, tracking stem cell lineage\, and studying the effectiveness of biological therapies. Additionally\, the need for antibody-based high parameter protein analysis is underscored by its capacity to identify rare and previously uncharacterized cell populations. This ability has far reaching implications in both basic research and into translational research. \nSpeakers: \nDaniel Frederick\, PhD\, Mass Cytometry Application Scientist \nEric Swanson\, PhD\, Imaging Mass Cytometry Application Scientist \nIn this seminar: \n(a) we will describe the principles of the Helios™\, CyTOF® mass cytometry system\, the utility of high parameter analysis\, and highlight ground-breaking research made possible with mass cytometry. \n(b) we will describe the principles and workflow of the Hyperion™ Tissue Imaging System\, and highlight ground-breaking research made possible with imaging mass cytometry.
URL:https://scienceinboston.com/event/technical-seminar-mass-cytometry-for-highly-multiplexed-analysis-2/
LOCATION:Koch Institute for Integrative Cancer Research\, 500 Main Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191203T100000
DTEND;TZID=America/New_York:20191203T140000
DTSTAMP:20260716T043357
CREATED:20191118T152515Z
LAST-MODIFIED:20191118T152515Z
UID:7243-1575367200-1575381600@scienceinboston.com
SUMMARY:Technical Seminar Lunch-and-Learn Day
DESCRIPTION:The technical seminar you don’t want to miss.\n\n\n\n\n\n\nAbout this Event\n\n\nDevelopment to Market: Early Stage Considerations for Late Stage Success \nFeaturing Patti Seymour of BDO\, Hugh Davis of Frontage Laboratories\, Richard Richieri of Avid Bioservices\, and Arugadoss Devakumar of Avid Bioservices. \n\n\n\n\n\n300 Technology Square
URL:https://scienceinboston.com/event/technical-seminar-lunch-and-learn-day/
LOCATION:300 Technology Square\, 300 Technology Square\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191203T100000
DTEND;TZID=America/New_York:20191203T140000
DTSTAMP:20260716T043357
CREATED:20191118T152515Z
LAST-MODIFIED:20191118T152515Z
UID:27393-1575367200-1575381600@scienceinboston.com
SUMMARY:Technical Seminar Lunch-and-Learn Day
DESCRIPTION:The technical seminar you don’t want to miss.\n\n\n\n\n\n\nAbout this Event\n\n\nDevelopment to Market: Early Stage Considerations for Late Stage Success \nFeaturing Patti Seymour of BDO\, Hugh Davis of Frontage Laboratories\, Richard Richieri of Avid Bioservices\, and Arugadoss Devakumar of Avid Bioservices. \n\n\n\n\n\n300 Technology Square
URL:https://scienceinboston.com/event/technical-seminar-lunch-and-learn-day-2/
LOCATION:300 Technology Square\, 300 Technology Square\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191203T173000
DTEND;TZID=America/New_York:20191203T183000
DTSTAMP:20260716T043357
CREATED:20191118T152801Z
LAST-MODIFIED:20191118T152801Z
UID:7247-1575394200-1575397800@scienceinboston.com
SUMMARY:Catenion Consulting Info Session
DESCRIPTION:Description\n\n\n\nThis interactive info session will feature current consultants from Catenion\, a multinational company specialized in life-science consulting with officies in Boston\, London\, Berlin and Tokyo. Join us to learn about Catenion’s history and vision\, areas of interest\, work and life at Catenion and how their consultants transitioned into this career path. Participants will have the chance to ask questions and network with the company professionals. \nCatenion is a management consulting firm devoted to helping pharmaceutical and medical products companies create more innovative and effective strategies and organisations. The company draws on their deep understanding of industry trends and company dynamics to help their clients develop actionable competitive strategies. They also address the cultural impediments to pharmaceutical innovation by helping clients create the organisational climates that foster creativity and medical breakthroughs. At the same time they also greatly improve how their clients assess the value and risk of their project and product portfolios and how they allocate resources. \nSign up now to learn more about Catenion!
URL:https://scienceinboston.com/event/catenion-consulting-info-session/
LOCATION:MGH\,100 Blossom Street  Cox Floor 3\, Conference room 370\, 100 Blossom Street\, Boston\, MA\, 02114\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191203T173000
DTEND;TZID=America/New_York:20191203T183000
DTSTAMP:20260716T043357
CREATED:20191118T152801Z
LAST-MODIFIED:20191118T152801Z
UID:27394-1575394200-1575397800@scienceinboston.com
SUMMARY:Catenion Consulting Info Session
DESCRIPTION:Description\n\n\n\nThis interactive info session will feature current consultants from Catenion\, a multinational company specialized in life-science consulting with officies in Boston\, London\, Berlin and Tokyo. Join us to learn about Catenion’s history and vision\, areas of interest\, work and life at Catenion and how their consultants transitioned into this career path. Participants will have the chance to ask questions and network with the company professionals. \nCatenion is a management consulting firm devoted to helping pharmaceutical and medical products companies create more innovative and effective strategies and organisations. The company draws on their deep understanding of industry trends and company dynamics to help their clients develop actionable competitive strategies. They also address the cultural impediments to pharmaceutical innovation by helping clients create the organisational climates that foster creativity and medical breakthroughs. At the same time they also greatly improve how their clients assess the value and risk of their project and product portfolios and how they allocate resources. \nSign up now to learn more about Catenion!
URL:https://scienceinboston.com/event/catenion-consulting-info-session-2/
LOCATION:MGH\,100 Blossom Street  Cox Floor 3\, Conference room 370\, 100 Blossom Street\, Boston\, MA\, 02114\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191204T073000
DTEND;TZID=America/New_York:20191204T093000
DTSTAMP:20260716T043357
CREATED:20191122T165520Z
LAST-MODIFIED:20191122T165520Z
UID:7301-1575444600-1575451800@scienceinboston.com
SUMMARY:Breakfast at LabShares: Technology Licensing Officers and Associates
DESCRIPTION:Overview\n\nLabShares is a biotech incubator with rentable benches boasting a comprehensive equipment list\, multiple on-site amenities and is staffed by skilled admins available to take the operational tasks off of startups so they can focus on science. \nWe’d like to invite reps from our local licensing offices to come to our space for a delicious\, free breakfast where we’ll present on our model\, benefits and the perks of our space for a company beginning to outgrow their academic incubator. Did we mention our extensive\, free parking? \nThis event is for licensing representatives only; while we appreciate those in sales’ interest in our space\, our information session will be tailored to professionals working in licensing. We ask representatives from sales backgrounds to sign up for our mailing list to keep up to date on events geared towards product marketing and sales professionals.
URL:https://scienceinboston.com/event/breakfast-at-labshares-technology-licensing-officers-and-associates/
LOCATION:LabShares Newton\, LLC\, 90 Bridge Street\, Newton\, MA\, 02458\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191204T073000
DTEND;TZID=America/New_York:20191204T093000
DTSTAMP:20260716T043357
CREATED:20191122T165520Z
LAST-MODIFIED:20191122T165520Z
UID:27397-1575444600-1575451800@scienceinboston.com
SUMMARY:Breakfast at LabShares: Technology Licensing Officers and Associates
DESCRIPTION:Overview\n\nLabShares is a biotech incubator with rentable benches boasting a comprehensive equipment list\, multiple on-site amenities and is staffed by skilled admins available to take the operational tasks off of startups so they can focus on science. \nWe’d like to invite reps from our local licensing offices to come to our space for a delicious\, free breakfast where we’ll present on our model\, benefits and the perks of our space for a company beginning to outgrow their academic incubator. Did we mention our extensive\, free parking? \nThis event is for licensing representatives only; while we appreciate those in sales’ interest in our space\, our information session will be tailored to professionals working in licensing. We ask representatives from sales backgrounds to sign up for our mailing list to keep up to date on events geared towards product marketing and sales professionals.
URL:https://scienceinboston.com/event/breakfast-at-labshares-technology-licensing-officers-and-associates-2/
LOCATION:LabShares Newton\, LLC\, 90 Bridge Street\, Newton\, MA\, 02458\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191204T080000
DTEND;TZID=America/New_York:20191204T100000
DTSTAMP:20260716T043357
CREATED:20191122T165249Z
LAST-MODIFIED:20191122T165249Z
UID:7299-1575446400-1575453600@scienceinboston.com
SUMMARY:Closing The Real-World Evidence Gap: Pragmatic Clinical Trials & Observational Studies
DESCRIPTION:Clinical trials are performed at specialized sites\, with entry criteria that selects subjects likely to show efficacy but who are not necessarily representative of the broad population of patients. There is increasing concern on the part of regulators that explanatory clinical trials\, which confirm a clinical hypothesis\, tend to overestimate the effectiveness and underestimate the safety of medicinal products and devices. The use of real-world evidence to support regulatory decision making is discussed in the FDA final guidance for medical devices (2017) and draft guidance for drugs and biologics (2019). The guidances outline prospective pragmatic clinical trials (PCTs) and retrospective observational studies as the means to bridge the gap between explanatory trials and adoption evaluation. In this forum\, our panel of experts will discuss the evolution and future of PCTs and observational studies as important tools for integration of real-world evidence in medical product development. \nSponsored by the Biostatistics\, Data Management & Clinical Trials (BSDMCT) Forum Working Group.
URL:https://scienceinboston.com/event/closing-the-real-world-evidence-gap-pragmatic-clinical-trials-observational-studies/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191204T080000
DTEND;TZID=America/New_York:20191204T100000
DTSTAMP:20260716T043357
CREATED:20191122T165249Z
LAST-MODIFIED:20191122T165249Z
UID:27396-1575446400-1575453600@scienceinboston.com
SUMMARY:Closing The Real-World Evidence Gap: Pragmatic Clinical Trials & Observational Studies
DESCRIPTION:Clinical trials are performed at specialized sites\, with entry criteria that selects subjects likely to show efficacy but who are not necessarily representative of the broad population of patients. There is increasing concern on the part of regulators that explanatory clinical trials\, which confirm a clinical hypothesis\, tend to overestimate the effectiveness and underestimate the safety of medicinal products and devices. The use of real-world evidence to support regulatory decision making is discussed in the FDA final guidance for medical devices (2017) and draft guidance for drugs and biologics (2019). The guidances outline prospective pragmatic clinical trials (PCTs) and retrospective observational studies as the means to bridge the gap between explanatory trials and adoption evaluation. In this forum\, our panel of experts will discuss the evolution and future of PCTs and observational studies as important tools for integration of real-world evidence in medical product development. \nSponsored by the Biostatistics\, Data Management & Clinical Trials (BSDMCT) Forum Working Group.
URL:https://scienceinboston.com/event/closing-the-real-world-evidence-gap-pragmatic-clinical-trials-observational-studies-2/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191204T170000
DTEND;TZID=America/New_York:20191204T190000
DTSTAMP:20260716T043357
CREATED:20191118T223826Z
LAST-MODIFIED:20191118T223826Z
UID:7258-1575478800-1575486000@scienceinboston.com
SUMMARY:Careers after PhD: A Panel Discussion and Networking Event for Life Science PhDs
DESCRIPTION:STEMCELL Technologies and Science in Boston invite you to attend an exclusive career and networking night exploring science careers outside of academia. The evening will feature keynote speaker Dr. Nicole Quinn\, Associate Director of Scientific Communications at STEMCELL Technologies\, who will discuss her career transition from academia to science communications and offer tangible advice for identifying and pursuing various careers outside of academic research. This will be followed by a panel discussion with industry experts\, who will share their experience and expertise in a myriad of career options. Food and refreshments will be provided. \nPlease RSVP before December 1 to reserve your spot! \n\n\nKeynote Speaker\n\n\n\n\n\n\nNicole Quinn\, PhD\nAssociate Director\, Scientific Communications\nSTEMCELL Technologies\n\n\n\n\n\n\n\n\nPanelists\n\n\n\n\n\n\nMichelle Stolzoff\, PhD\nSr. Technical Writer\nTakeda\n\n\n\n\n\n\n\n\n\nRachit Neupane\, PhD\nSenior Associate\nClarion Healthcare\n\n\n\n\n\n\n\n\n\n\nBenjamin Arellano\, PhD\nImmunology and Cell Separation Specialist\nSTEMCELL Technologies\n\n\n\n\n\n\n\n\n\n\nCarla D’Avanzo\, PhD\nStrategic Alliances Program Manager\nMass General Research Institute\n\n\n\n\n\n\n\n\n\nTime:Wednesday\, December 4\, 5:00 p.m. – 7:00 p.m. \nLocationSTEMCELL Technologies Inc. Cambridge Office\n222 Third Street\, Suite 2323\, Cambridge\, MA
URL:https://scienceinboston.com/event/careers-after-phd-a-panel-discussion-and-networking-event-for-life-science-phds/
LOCATION:STEMCELL Tech\, Suite 2323-222 Third Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191204T170000
DTEND;TZID=America/New_York:20191204T190000
DTSTAMP:20260716T043357
CREATED:20191118T223826Z
LAST-MODIFIED:20191118T223826Z
UID:27395-1575478800-1575486000@scienceinboston.com
SUMMARY:Careers after PhD: A Panel Discussion and Networking Event for Life Science PhDs
DESCRIPTION:STEMCELL Technologies and Science in Boston invite you to attend an exclusive career and networking night exploring science careers outside of academia. The evening will feature keynote speaker Dr. Nicole Quinn\, Associate Director of Scientific Communications at STEMCELL Technologies\, who will discuss her career transition from academia to science communications and offer tangible advice for identifying and pursuing various careers outside of academic research. This will be followed by a panel discussion with industry experts\, who will share their experience and expertise in a myriad of career options. Food and refreshments will be provided. \nPlease RSVP before December 1 to reserve your spot! \n\n\nKeynote Speaker\n\n\n\n\n\n\nNicole Quinn\, PhD\nAssociate Director\, Scientific Communications\nSTEMCELL Technologies\n\n\n\n\n\n\n\n\nPanelists\n\n\n\n\n\n\nMichelle Stolzoff\, PhD\nSr. Technical Writer\nTakeda\n\n\n\n\n\n\n\n\n\nRachit Neupane\, PhD\nSenior Associate\nClarion Healthcare\n\n\n\n\n\n\n\n\n\n\nBenjamin Arellano\, PhD\nImmunology and Cell Separation Specialist\nSTEMCELL Technologies\n\n\n\n\n\n\n\n\n\n\nCarla D’Avanzo\, PhD\nStrategic Alliances Program Manager\nMass General Research Institute\n\n\n\n\n\n\n\n\n\nTime:Wednesday\, December 4\, 5:00 p.m. – 7:00 p.m. \nLocationSTEMCELL Technologies Inc. Cambridge Office\n222 Third Street\, Suite 2323\, Cambridge\, MA
URL:https://scienceinboston.com/event/careers-after-phd-a-panel-discussion-and-networking-event-for-life-science-phds-2/
LOCATION:STEMCELL Tech\, Suite 2323-222 Third Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191206T080000
DTEND;TZID=America/New_York:20191206T170000
DTSTAMP:20260716T043357
CREATED:20191122T165805Z
LAST-MODIFIED:20191122T165805Z
UID:7305-1575619200-1575651600@scienceinboston.com
SUMMARY:Yale Lifesciences Pitchfest
DESCRIPTION:Overview\n\nYale Lifesciences Pitchfest is a full day where the top 32 biotech opportunities developing within Yale take the stage to present their 5-minute pitches to industry. The 32 presenting investigators will be competing for $4500 in prizes to be awarded at the end of the day\, but\, more importantly\, all advance as semifinalists in the annual Blavatnik Fund for Innovation at Yale competition\, which will make nearly $3 million in awards in May 2020. \nYale Lifesciences Pitchfest is presented by the Blavatnik Fund for Innovation at Yale.  The Blavatnik Fund helps to accelerate the development of important early-stage discoveries in the life sciences into medical or commercial applications by awarding pilot grants to support exploratory and proof-of-concept activities\, as well as larger development grants for more established projects.  Over its first three years\, the fund has made 21 awards for Yale projects totaling $5 million. \nFor more info see: \nhttps://blavatnik.ocr.yale.edu
URL:https://scienceinboston.com/event/yale-lifesciences-pitchfest/
LOCATION:Alexion Pharmaceuticals\, 100 College St\, New Haven\, CT\, 06510\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191206T080000
DTEND;TZID=America/New_York:20191206T170000
DTSTAMP:20260716T043357
CREATED:20191122T165805Z
LAST-MODIFIED:20191122T165805Z
UID:27398-1575619200-1575651600@scienceinboston.com
SUMMARY:Yale Lifesciences Pitchfest
DESCRIPTION:Overview\n\nYale Lifesciences Pitchfest is a full day where the top 32 biotech opportunities developing within Yale take the stage to present their 5-minute pitches to industry. The 32 presenting investigators will be competing for $4500 in prizes to be awarded at the end of the day\, but\, more importantly\, all advance as semifinalists in the annual Blavatnik Fund for Innovation at Yale competition\, which will make nearly $3 million in awards in May 2020. \nYale Lifesciences Pitchfest is presented by the Blavatnik Fund for Innovation at Yale.  The Blavatnik Fund helps to accelerate the development of important early-stage discoveries in the life sciences into medical or commercial applications by awarding pilot grants to support exploratory and proof-of-concept activities\, as well as larger development grants for more established projects.  Over its first three years\, the fund has made 21 awards for Yale projects totaling $5 million. \nFor more info see: \nhttps://blavatnik.ocr.yale.edu
URL:https://scienceinboston.com/event/yale-lifesciences-pitchfest-2/
LOCATION:Alexion Pharmaceuticals\, 100 College St\, New Haven\, CT\, 06510\, United States
END:VEVENT
END:VCALENDAR